ADRO Shares Outstanding History
Below is a table of the ADRO shares outstanding history going back to 4/15/2015:

Date ADRO Shares Outstanding
4/15/201557.15M
5/26/201562.23M
8/6/201562.28M
11/20/201563.22M
3/2/201664.52M
4/25/201664.61M
7/31/201664.75M
10/31/201667.18M
2/23/201768.00M
4/26/201769.91M
7/26/201774.61M
10/25/201777.30M
2/23/201881.01M
4/27/201878.73M
7/27/201879.06M
10/26/201879.40M
2/22/201979.71M
5/3/201980.04M
7/29/201980.14M
11/4/201980.51M

Also see: ADRO Market Cap History
and ADRO YTD Return
ADRO Historical Shares Outstanding:
+7.81% CAGR
ADRO Historical Shares Outstanding: +7.81% CAGR

Mouse over chart for data details
4/15/2015 ...11/4/2019
Aduro Biotech is an immunotherapy company focused on the discovery, development and commercialization of therapies for the treatment of patients with diseases, including cancer. Co.'s primary technologies related to the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand pathways have a pipeline of clinical candidates including ADU-S100 (MIW815), ADU-S100 with spartalizumab, ADU-S100 with ipilimumab, ADU-S100 with anti-PD-1, cGAS-STING pathway inhibitor program, and BION-1301. Co.'s other programs consist of Anti-CD27 Antibody, which is a co-stimulatory receptor expressed on different immune cells, such as T-lymphocytes and NK cells. We show 20 historical shares outstanding datapoints in our coverage of ADRO's shares outstanding history.

Understanding the changing numbers of ADRO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADRO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADRO by allowing them to research ADRO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ADRO:
ADRO SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aduro Biotech (ADRO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ADUS Shares Outstanding History
ADVM Shares Outstanding History
ADXS Shares Outstanding History
AEMD Shares Outstanding History
AERI Shares Outstanding History
AEZS Shares Outstanding History
AGEN Shares Outstanding History
AGIO Shares Outstanding History
AGLE Shares Outstanding History
AGN Shares Outstanding History
More Healthcare companies »

 

ADRO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.